Results 161 to 170 of about 16,072 (215)

Non-Coding RNAs as Emerging Biomarkers in Leishmaniasis and Chagas Disease. [PDF]

open access: yesTrop Med Infect Dis
Ramos Juárez E   +15 more
europepmc   +1 more source

Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis. [PDF]

open access: yesEur J Microbiol Immunol (Bp)
Jensen BB   +10 more
europepmc   +1 more source

Unusual report of an immunocompetent patient with atypical cutaneous leishmaniasis caused by Leishmania (Leishmania) infantum in Minas Gerais, Brazil. [PDF]

open access: yesRev Soc Bras Med Trop
Rocha RM   +15 more
europepmc   +1 more source

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin. [PDF]

open access: yesInt J Mol Sci
Melcón-Fernández E   +6 more
europepmc   +1 more source

Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis

Experimental Parasitology, 2011
Leishmaniasis is a family of diseases caused by protozoan parasites of the genus Leishmania. Various Leishmania species can cause human infection, producing a spectrum of clinical manifestations. The current treatments are unsatisfactory, and in absence of a vaccine, there is an urgent need for effective drugs to replace/supplement those currently in ...
Maha M Eissa
exaly   +3 more sources

Experimental cutaneous leishmaniasis

Acta Tropica, 1997
Lourdes Maria Garcez   +4 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy